AM

Aamir Mir

IN Inscripta: 5 patents #3 of 31Top 10%
Overall (2022): #35,080 of 548,613Top 7%
5
Patents 2022

Issued Patents 2022

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
11359187 Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells Andrew Garst, Stephen Federowicz, Kyle Seamon 2022-06-14
11345903 Engineered enzymes Benjamin Mijts, Juhan Kim, Kyle Seamon, Andrew Garst 2022-05-31
11332742 Mad nucleases Juhan Kim, Benjamin Mijts 2022-05-17
11306298 Mad nucleases Juhan Kim, Benjamin Mijts 2022-04-19
11286471 Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells Andrew Garst, Stephen Federowicz, Kyle Seamon 2022-03-29